Wednesday, February 22, 2012

For more information about pneumococcal...

Vaccines exist for some types of pneumococcal disease, but they do not work for every kind of disease or for those who need protection. PATH is looking for pneumococcal vaccine, which protects children worldwide against this deadly infection. Pneumoniae, or pneumococcus


onion bacteria absorption

causes pneumonia and infections of the brain and bloodand death more than 800 000 children under five years. Vaccines exist that can protect children now and they should be used, but they only protect against certain types of bacteria and in many countries of the developing world can not afford without assistance. Additional, less expensive vaccines, ultimately, necessary for the protection of children in low income countries, where most deaths are pneumococcus. One approach, which has particular promise the development of general vaccine protein order strattera. Some proteins are common to all types of pneumococcus. The vaccine containing these proteins can provide broad protection. PATH is working to identify potential new vaccines and to help researchers in their development. For example, have been cataloging collections pneumococcus around the world (researchers should have access to different types!) Figuring out how best to evaluate vaccine candidates as they are developed, and identify ways to streamline the production of new vaccines, so that when they become available, they are available for health systems in countries with low income. Through experience allows partnerships to identify both public and private sector resources and expertise. We appeal to researchers in universities and biotech companies, vaccine manufacturers, as well as various international health partnersto every individual and institution that can help realize our goals and accelerate progress. We recently put forward a candidate vaccine in clinical trials and expect the same for a larger number of candidates in the next few years. The goal is to develop a vaccine that is safe, effective and affordable, and offers a defense of vaccine that is a match for pneumococcal diseases affecting children in developing countries. For more information about pneumococcal infections and vaccines, please see our. Photo above: PATH / Julie Jacobson, Wendy Stone. .

No comments:

Post a Comment